GSK3 function in floral organs and cell expansion
Molecular
and genetic analysis has confirmed roles for Arabidopsis GSK3s in the development of flowers and reproductive
organs. AtSK11 and AtSK12 show specific strong expression
in early floral meristems, which later becomes restricted to sepal primordia,
petals, carpels and the pollen-containing regions of the anthers [45]. Within the carpels, AtSK11
and AtSK12 expression concentrates on
adaxial sides (nearest the central axis) of the carpels and in ovule primordia,
particularly in the integuments and megaspore mother cell [45]. A quantitative RT-PCR study of all ten Arabidopsis GSK3s revealed that a third
GSK3, AtSK31, was also expressed
relatively highly in floral organs [46]. Moreover, the AtSK31
protein localizes to the nuclei of developing tissues, particularly in floral
organs, gametophytes and embryos [47].
Consistent with the expression data, antisense reduction in
either AtSK11 or AtSK12 transcript levels results in disrupted cell division in the
floral meristem, in flowers with increased numbers of sepals and petals, and in
abnormal carpel development [45]. Interestingly, overexpression of different AtSK32 isoforms in wild-type Arabidopsis causes varying effects [48]. Overexpression of either wild-type AtSK32 or a kinase-dead mutant (K167A) resulted in no detectable
phenotype [48]. However, overexpression of a mutant specifically unable to
phosphorylate primed GSK3 substrates (R178A; Figure 1) resulted in plants with
short hypocotyls and reduced cell elongation in floral organs. Accordingly, AtSK32 (K167A)-overexpressing plants
showed a marked downregulation of the genes encoding several cell
wall-modifying enzymes involved in cell elongation [48]. This suggests that GSK3-mediated cell elongation responses
may require the action of primed GSK3 substrates. It is likely that in addition
to floral cell expansion, GSK3s may have a more general role in cell elongation
in the plant given that BRs are instrumental in controlling cell elongation and
dominant bin2/ucu1 mutants show cell elongation defects in leaves [19]. Given that GSK3 targets BZR1 and BES1 do not require a
priming phosphorylation [21,30], it seems that new targets of AtSK32 await discovery.
Post Comment
No comments